ARGENT BIOPHARMA Stock Price, News & Analysis
MGCLF
OTC
Company Description
Argent BioPharma, formerly known as MGC Pharmaceuticals Ltd, is a leading biopharmaceutical company specializing in innovative drug development. The company has recently undergone a comprehensive restructuring to embrace cutting-edge Polypharmacology and Nanotechnology. With a focus on addressing multifactorial diseases through IMPs and early access treatments, Argent BioPharma is dedicated to advancing immunology and neurology treatments, including CannEpil® for refractory epilepsy and CimetrA® for acute lung injury. Committed to global accessibility and innovation, the company aims to lead the biopharmaceutical industry with integrity, diversity, and excellence.
Stock Performance
$—
0.00%
0.00
Last updated:
- %
Performance 1 year
$12.1M
Market Cap
45.3M
Shares outstanding
Latest News
SEC Filings
No SEC filings available for ARGENT BIOPHARMA.
Financial Highlights
—
Revenue (TTM)
—
Net Income (TTM)
—
Diluted EPS (TTM)
—
Operating Cash Flow
—
Net Profit Margin
—
Oper. Profit Margin
Upcoming Events
Frequently Asked Questions
What is the current stock price of ARGENT BIOPHARMA (MGCLF)?
The current stock price of ARGENT BIOPHARMA (MGCLF) is $0.2675 as of February 7, 2025.
What is the market cap of ARGENT BIOPHARMA (MGCLF)?
The market cap of ARGENT BIOPHARMA (MGCLF) is approximately 12.1M.
What is Argent BioPharma?
Argent BioPharma is a leading biopharmaceutical company that specializes in innovative drug development, focusing on Polypharmacology and Nanotechnology.
What are the core products of Argent BioPharma?
Argent BioPharma's core products include CannEpil® for refractory epilepsy, CimetrA® for acute lung injury, and CogniCann® for dementia and Alzheimer's disease, developed using Polypharmacology.
What is the strategic focus of Argent BioPharma?
Argent BioPharma strategically focuses on generating revenue through Investigational Medicinal Products (IMP) and early access treatments in major markets like the UK, USA, and Europe.
What is the vision of Argent BioPharma?
Argent BioPharma aims to become a globally recognized leader in the biopharmaceutical industry by addressing unmet medical needs through Polypharmacology and Nanotechnology.
What are the core values of Argent BioPharma?
Argent BioPharma's core values include integrity, diversity, teamwork, accountability, and excellence, supported by strong Environmental, Social, and Governance principles.
How does Argent BioPharma contribute to the biopharmaceutical industry?
Argent BioPharma contributes to the industry by pioneering life science innovations, ensuring global accessibility, fostering consistent innovation, and achieving industry leadership.
What are the achievements of Argent BioPharma?
Argent BioPharma has recently rebranded from MGC Pharmaceuticals Ltd to mark a significant milestone in its evolutionary journey, incorporating American capital and operational revisions.
Where is Argent BioPharma listed?
Argent BioPharma is listed on both the London Stock Exchange and the Australian Stock Exchange.
What is Argent BioPharma's mission?
Argent BioPharma's mission is centered on researching and developing innovative treatments for global health challenges, guided by its strategic pillars of pioneering life science innovations.
How does Argent BioPharma ensure high-quality production?
Argent BioPharma adheres to strict EU GMP and GDP guidelines at its two specialized manufacturing sites, ensuring high-quality production standards.
What is the focus of Argent BioPharma's European research and development center?
Argent BioPharma's European research and development center plays a crucial role in the entire drug development process, from concept to market launch, focusing on innovation in drug development.
How does Argent BioPharma approach drug development?
Argent BioPharma innovates with Polypharmacology, targeting multiple molecular targets to address complex multifactorial diseases and set new benchmarks in drug development and therapeutic outcomes.